Press Releases

 
Press Releases
  Date Title View
Nov 3, 2016
Third Quarter Revenue Increased 28% Versus Prior Year to $10.8 millionePlex® Gaining Momentum in Europe; Preparation for U.S. Launch UnderwayePlex Clinical Sample Testing Completed at Clinical Study Sites; Q4 FDA Submission on TrackCompleted $29 Million ATM Offering; Ended Q3 with Cash Balance of $54.2 milli...
PDF
Nov 1, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the Canaccord Genuity Medical Technologies & Diagnostics Form ...
PDF
Oct 20, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Thursday, November 3, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on...
PDF
Jul 28, 2016
Second Quarter Revenue Increased 64% Versus Prior Year to $12.5 millionePlex® Systems Installed at Twelve European CustomersePlex FDA Submission Expected in Fourth Quarter CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of ...
PDF
Jul 27, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the 36th Annual Canaccord Genuity Growth Conference to be ...
PDF
Jul 14, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Thursday, July 28, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on ...
PDF
Jun 8, 2016
European Customer Agreements in Place for Initial Systems CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In‐Vitro Di...
PDF
Jun 6, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the William Blair 36th Annual Growth Stock Conference to be ...
PDF
May 3, 2016
First Quarter Revenue Increased 9% Versus Prior Year to $11.1 millionePlex CE Mark Expected in Second Quarter CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today ...
PDF
Apr 19, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 3, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on the s...
PDF
1
...
NextLast